Bottom-up manufacturing of artificial anti-tumor T cells

Project Information

ArTCell

Grant agreement ID: 101130715

DOI

10.3030/101130715

EC signature date 9 October 2023

Start date 1 February 2024

End date 31 January 2029

Funded under

• The European Innovation Council (EIC)

Total cost

€ 3 391 796,25

EU contribution

€ 3 391 796,25

Coordinated by

KATHOLIEKE UNIVERSITEIT LEUVEN
Belgium

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Documents, reports (1)

Project website and logo

Website and project logo information with also social media links.

Data Management Plan (1)

Data Management Plan

A data management plan according to the EC rules will be established for the project in M3 and periodically updated throughout the project.

Publications

Other (1)

Lipid nanoparticles-based RNA therapies for breast cancer treatment

Author(s): Luigia Serpico; Yuewen Zhu; Renata Faria Maia; Sumedha Sumedha; Mohammad-Ali Shahbazi; Hlder A. Santos
Published in: Drug Delivery and Translational Research, 2024
Publisher: Springer
DOI: 10.1007/s13346-024-01638-2